The assumption that biological response triggers in asthma can be modulated by the levels of cyclic nucleotides aroused the interest in phosphodiesterases (PDE), as targets for new drugs to treat asthma and others pulmonary diseases. The gene discussed is ALDH7A1; the disease is asthma.